Wednesday, January 16, 2013
Durham Drug Being Tested in Late-Phase Clinical Trials
Argos Therapeutics Inc., a Durham company developing personalized treatments for cancer and infectious diseases, announced Tuesday that a late-phase clinical trial has launched that’s testing its most advanced product candidate in kidney cancer patients.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment